NanoVibronix, Inc. (NAOV)

0.7201 -0.0209 (-2.82%) At close: 04:00PM EDT

NanoVibronix, Inc.

969 Pruitt Avenue
Tyler, TX 77569
United States
(914) 233-3004
https://www.nanovibronix.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 10

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Brian M. Murphy	CEO & Director	382.5k	N/A	1957
Mr. Stephen R. Brown CPA	Chief Financial Officer	292.5k	N/A	1956
Dr. Harold Jacob M.D.	Chief Medical Officer & Director	N/A	N/A	1954
Mr. Amir Rippel	Vice President of Marketing	N/A	N/A	N/A
Ms. Lindsey Harrison	Vice President of Sales	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the non-invasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy in the United States, Israel, Europe, Australia, India, and internationally. The company's product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. It also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements. The company was incorporated in 2003 and is headquartered in Tyler, Texas.

Corporate governance

NanoVibronix, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.